JPMorgan Diversified Return International Eqty ETF vs Liquidia Corporation Common Stock — how do they compare? JPMorgan Diversified Return International Eqty ETF trades at $73 (market cap $380.28M), while Liquidia Corporation Common Stock trades at $34.2 (market cap $3.04B). The key difference: Liquidia Corporation Common Stock is far larger — about 8× JPMorgan Diversified Return International Eqty ETF's market cap, and JPMorgan Diversified Return International Eqty ETF is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold JPMorgan Diversified Return International Eqty ETF for 121 Days and Liquidia Corporation Common Stock for 0 Days on average.
| JPIN | LQDA | |
|---|---|---|
Market Cap | $380.28M | $3.04B |
Volume | 4,689 | 21,111,778 |
52-Week High | $77.80 | $91.03 |
52-Week Low | $65.86 | $22.02 |
Typical Hold Time | 121 Days | 0 Days |
Sector | — | Health |
Enterprise Value | — | $2.94B |
Signals from Pluang's Aura AI — not financial advice
JPIN trades at $73.52, up 0.65% with bearish technical signals dominating. The ETF shows oversold RSI readings but faces strong selling pressure across moving averages and ADX indicators. Support and resistance cluster tightly around $73-74, suggesting potential for near-term volatility. Recent dividend announcement for September 2026 provides future income potential.
The ETF's outlook remains challenged by bearish momentum despite oversold conditions. Investment opportunity exists for value investors seeking international equity exposure, though risks include continued technical weakness and market volatility. The concentrated price action around current levels indicates potential breakout or breakdown scenario ahead.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
The fund will invest at least 80% of its assets in securities included in the underlying index. The underlying index is comprised of equity securities across developed global markets (excluding North America) selected to represent a diversified set of factor characteristics.
Read more on JPIN →Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →